NCT00005985View on ClinicalTrials.gov

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

dexamethasone

DRUG

etoposide

DRUG

mitoxantrone hydrochloride

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

55455

University of Minnesota Cancer Center, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT00005985 - Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter